These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 21983283)

  • 1. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface-modified LPD nanoparticles for tumor targeting.
    Li SD; Huang L
    Ann N Y Acad Sci; 2006 Oct; 1082():1-8. PubMed ID: 17145918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells.
    Kowalski PS; Kuninty PR; Bijlsma KT; Stuart MC; Leus NG; Ruiters MH; Molema G; Kamps JA
    Eur J Pharm Biopharm; 2015 Jan; 89():40-7. PubMed ID: 25460585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anginex lipoplexes for delivery of anti-angiogenic siRNA.
    Yousefi A; Bourajjaj M; Babae N; Noort PI; Schaapveld RQ; Beijnum JR; Griffioen AW; Storm G; Schiffelers RM; Mastrobattista E
    Int J Pharm; 2014 Sep; 472(1-2):175-84. PubMed ID: 24950365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells.
    Adrian JE; Morselt HW; Süss R; Barnert S; Kok JW; Asgeirsdóttir SA; Ruiters MH; Molema G; Kamps JA
    J Control Release; 2010 Jun; 144(3):341-9. PubMed ID: 20226822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling.
    Kou R; SenBanerjee S; Jain MK; Michel T
    Biochemistry; 2005 Nov; 44(45):15064-73. PubMed ID: 16274253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.
    Gao J; Yu Y; Zhang Y; Song J; Chen H; Li W; Qian W; Deng L; Kou G; Chen J; Guo Y
    Biomaterials; 2012 Jan; 33(1):270-82. PubMed ID: 21963149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes.
    Gao J; Liu W; Xia Y; Li W; Sun J; Chen H; Li B; Zhang D; Qian W; Meng Y; Deng L; Wang H; Chen J; Guo Y
    Biomaterials; 2011 May; 32(13):3459-70. PubMed ID: 21296406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
    Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
    Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
    Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
    J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
    Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
    J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.